ShareValue scores for DCAL.NSE: Valuation 81, Quality 33, Growth 30, Health 47.

DCAL.NSE
NSE

Dishman Carbogen Amcis Limited

₹194.66(-0.39%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

13% to 29%
Valuation
81
Undervalued
Price vs Value
Quality
33
Weak
Business Strength
Growth
30
Weak
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
48
Neutral
Price Trend

Company Details

About

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026